USA
Intellectual Property
Healthcare
June 2022
Vol.15, No. 59, Spring 2022
Stacy Lewis
More
Stacy Lewis is called to the bar in New York and has worked as a law clerk at Finnegan since 1995. She focuses on research and writing, particularly in the life sciences. She is the coordinating editor of the books Global Patent Litigation: How and Where to Win and Design Patent Law, as well as the coursebook Chemical Patent Practice. Stacy sits on the AIPLA Quarterly Journal and IPO Law Journal editorial boards. She can be reached at stacy.lewis@finnegan.com.
Angela Sebor
More
Angie Sebor is the Director Intellectual Property at Tolmar, Inc., a Colorado-based, fully integrated pharmaceutical company focused on developing innovative, specialty pharmaceutical products in the areas of urology, oncology, pediatric endocrinology and dermatology. Angie is a registered U.S. patent agent with a Ph.D. in Immunology and more than 25 years’ experience in patent law, both as an in-house practitioner and in private practice, primarily in the areas of biotechnology and pharmaceuticals.
Xiaoguang Michelle Gao
More
Dr. Gao is Assistant General Patent Counsel at Eli Lilly and Company. She obtained her Ph.D. in Molecular Biology from Northwestern University, and J.D. from the University of Illinois. Prior to joining Eli Lilly, she was a Patent Attorney at Novartis Institutes for BioMedical Research, where she supported ImmunoOncology and Neuroscience programs. She also worked for Fish & Richardson as an associate, focusing her practice on biopharma-related patent prosecution and litigation there.
Eli Lilly and Company
More
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: "Take what you find here and make it better and better."
More than 145 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.
Tolmar, Inc.
More
Tolmar is a Northern Colorado based pharmaceutical research, development, manufacturing and commercial operations company. Tolmar develops and manufactures both proprietary and generic pharmaceutical products with specific focus in dermatology, oncology, and specialty injectable therapeutic areas.
Finnegan
More
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the largest IP law firms in the world. With offices in Atlanta, Boston, London, Munich, Palo Alto, Reston, Seoul, Shanghai, Taipei, Tokyo and Washington, DC, the firm practices all aspects of patent, trademark, and copyright law, including counselling, prosecution, licensing and litigation. Finnegan also represents clients in IP issues relating to advertising, trade secrets, European patents and trademarks, international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust and unfair competition.
USA
Intellectual Property
Healthcare
June 2022
Vol.15, No. 59, Spring 2022